Skip to main content

Table 2 Effect of MSP participation status (participants versus non-participants with incident breast cancer) on death from breast cancer and all causes other than breast cancer based on n = 68,230 women aged 50–69 years

From: Isolating the effect of confounding from the observed survival benefit of screening participants — a methodological approach illustrated by data from the German mammography screening programme

 

Death from breast cancer

Death from all causes other than breast cancer

HR (95% CI)

HR (95% CI)

Models without adjustment

 MSP non-participants

1

1

 MSP participants

0.31 (0.29–0.32)

0.65 (0.62–0.69)

Models adjusted for age at diagnosis and year of diagnosis

 MSP non-participants

1

1

 MSP participants

0.30 (0.28–0.32)

0.62 (0.58–0.66)

Models adjusted for age at diagnosis, year of diagnosis and tumour stage

 MSP non-participants

1

 

 MSP participants

0.52 (0.50–0.55)

 
  1. MSP Mammography screening programme, HR Hazard ratio, CI Confidence interval